7/16/24 18:00 | 7/15/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gollob Jared | MA | O | Chief Me | M.dm | 82 | 2.08 | 0 | 40 | 71 | 95 | D | | | | | | | | | | | | | | |
7/16/24 18:00 | 7/15/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gollob Jared | MA | O | Chief Me | S.dm | -1,803 | 45.53 | 0 | -40 | -29 | 95 | D | | | | | | | | | | | | | | |
3/4/24 18:21 | 3/4/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gollob Jared | MA | O | Chief Me | S.d | -140 | 41.86 | 0 | -3 | -3 | 96 | D | | | | | | | | | | | | | | |
2/9/24 19:47 | 2/9/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gollob Jared | MA | O | Chief Me | M.d | 96 | 2.08 | 0 | 46 | 161 | 75 | D | | | | | | | | | | | | | | |
2/9/24 19:47 | 2/9/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gollob Jared | MA | O | Chief Me | S.d | -1,638 | 35.50 | 0 | -46 | -38 | 75 | D | | | | | | | | | | | | | | |
3/3/23 16:30 | 3/2/23 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gollob Jared | MA | O | Chief Me | S.d | -40 | 31.00 | 0 | -1 | -2 | 75 | D | | | | | | | | | | | | | | |
5/4/22 09:02 | 5/4/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gollob Jared | MA | O | Chief Me | M.d | 34 | 1.69 | 0 | 20 | 54 | 57 | D | | | | | | | | | | | | | | |
11/2/21 18:45 | 11/1/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gollob Jared | MA | O | Chief Me | M.dm | 67 | 1.69 | 0 | 40 | | 25 | D | | | | | | | | | | | | | | |
11/2/21 18:45 | 11/1/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gollob Jared | MA | O | Chief Me | S.dm | -3,574 | 62.16 | 0 | -57 | -70 | 25 | D | | | | | | | | | | | | | | |
3/15/21 21:12 | 3/11/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gollob Jared | MA | O | Chief Me | M.dm | 13 | 1.31 | 0 | 10 | 31 | 43 | D | | | | | | | | | | | | | | |
3/15/21 21:12 | 3/11/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gollob Jared | MA | O | Chief Me | S.dm | -902 | 60.13 | 0 | -15 | -26 | 43 | D | | | | | | | | | | | | | | |
2/24/21 18:44 | 2/22/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gollob Jared | MA | O | Chief Me | S.m | -1,878 | 50.68 | 0 | -37 | -44 | 48 | D | | | | | | | | | | | | | | |
2/19/21 19:27 | 2/17/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gollob Jared | MA | O | Chief Me | S.m | -1,294 | 56.42 | 0 | -23 | -21 | 85 | D | | | | | | | | | | | | | | |